Frost Gregory Ian 4
4 · HALOZYME THERAPEUTICS INC · Filed Feb 6, 2013
Insider Transaction Report
Form 4
Frost Gregory Ian
DirectorVP and Chief Scientific Off.
Transactions
- Award
Option to Purchase Common Stock
2013-02-04$6.55/sh+65,000$425,750→ 65,000 totalExercise: $6.55Exp: 2023-02-04→ Common Stock (65,000 underlying) - Award
Restricted Stock Units
2013-02-04+39,000→ 39,000 totalExercise: $0.00Exp: 2023-02-04→ Common Stock (39,000 underlying)
Footnotes (2)
- [F1]This option vests one-fourth on such date and then 1/48 monthly thereafter.
- [F2]This award vests one-fourth on such date and then one-fourth on each anniversary thereafter.